British Indian pair fight extradition to US over alleged cancer drug fraud
A British Indian couple is contesting extradition to the US to face charges of smuggling unapproved drugs and defrauding Medicare. The defense argues that the US prison system poses risks to their health and safety, citing potential human rights concerns.
Why it matters
The case highlights the complexities of international legal cooperation and the scrutiny of prison conditions in extradition proceedings.
LONDON: A wealthy British Indian businessman and his ex-wife are battling extradition to the US, where they face charges of smuggling unapproved medical drugs from India into the US as well as defrauding US health insurance plans such as Medicare of millions of dollars.The allegations are that chemotherapy and other drugs were given to cancer patients at medical clinics owned by Sukhjit Singh Ghuman (48) and his former wife Kiranjit Ghuman (48), in California and Arizona between 2019 and 2023 despite being foreign unapproved drugs, some of which had expired, and they were given without the patients’ knowledge.It is alleged that the pair got the clinics to bill Medicare and other health insurance providers as though more expensive drugs approved by the US FDA were given to the cancer patients, pocketing the difference for financial gain.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in